Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other financing activities: 2012-2023

Historic Other financing activities for Enanta Pharmaceuticals (ENTA) over the last 7 years, with Sep 2023 value amounting to $325,000.

  • Enanta Pharmaceuticals' Other financing activities was N/A to -$5.5 million in Q2 2018 from the same period last year, while for Jun 2018 it was -$3.5 million, marking a year-over-year change of. This contributed to the annual value of $325,000 for FY2023, which is N/A change from last year.
  • Per Enanta Pharmaceuticals' latest filing, its Other financing activities stood at $325,000 for FY2023, which was up 52.58% from $213,000 recorded in FY2017.
  • Enanta Pharmaceuticals' 5-year Other financing activities high stood at $325,000 for FY2023, and its period low was $325,000 during FY2023.
  • For the 1-year period, Enanta Pharmaceuticals' Other financing activities averaged around $325,000, with its median value being $325,000 (2023).